Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II
about
A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.Structure of the EMAPII domain of human aminoacyl-tRNA synthetase complex reveals evolutionary dimer mimicryDeinococcus glutaminyl-tRNA synthetase is a chimer between proteins from an ancient and the modern pathways of aminoacyl-tRNA formationCrystal structure of Trbp111: a structure-specific tRNA-binding proteinRegulation of endothelial monocyte-activating polypeptide II release by apoptosisLung self-assembly is modulated by tissue surface tensionstRNA synthetase: tRNA aminoacylation and beyondEndothelial-Monocyte Activating Polypeptide II Suppresses the In Vitro Glioblastoma-Induced Angiogenesis by Inducing Autophagy.Cell proliferation and migration are modulated by Cdk-1-phosphorylated endothelial-monocyte activating polypeptide IIPelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation.New functions of aminoacyl-tRNA synthetases beyond translation.A recurrent general RNA binding domain appended to plant methionyl-tRNA synthetase acts as a cis-acting cofactor for aminoacylationVascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesisLung endothelial monocyte-activating protein 2 is a mediator of cigarette smoke-induced emphysema in miceThe N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.Control of stromal keratitis by inhibition of neovascularizationImmunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.The yeast protein Arc1p binds to tRNA and functions as a cofactor for the methionyl- and glutamyl-tRNA synthetases.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Endothelial-monocyte activating polypeptide II, a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells.Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.Combination of Endothelial-Monocyte-Activating Polypeptide-II with Temozolomide Suppress Malignant Biological Behaviors of Human Glioblastoma Stem Cells via miR-590-3p/MACC1 Inhibiting PI3K/AKT/mTOR Signal Pathway.Tumor-associated macrophages as major players in the tumor microenvironment.A random survey of the Cryptosporidium parvum genome.A monoclonal rat anti-mouse EMAP II antibody that functionally neutralizes pro- and mature-EMAP II in vitro.EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer.Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammationRegulation of EMAP II by hypoxia.Endothelial-monocyte activating polypeptide II disrupts alveolar epithelial type II to type I cell transdifferentiation.Autophagy Induction by Endothelial-Monocyte Activating Polypeptide II Contributes to the Inhibition of Malignant Biological Behaviors by the Combination of EMAP II with Rapamycin in Human Glioblastoma.Aminoacyl tRNA synthetase complex interacting multifunctional protein 1 simultaneously binds Glutamyl-Prolyl-tRNA Synthetase and Scaffold Protein Aminoacyl tRNA synthetase complex interacting multifunctional protein 3 of the Multi-tRNA Synthetase CoIsolation and characterization of a cDNA encoding a potential morphogen from the marine sponge Geodia cydonium that is conserved in higher metazoans.
P2860
Q24292091-4BC43560-4C13-405A-954D-E61DEBE79DDCQ24536732-8F18275F-F876-4E60-B5C3-850CA551D79CQ24673381-A3F61C71-5397-46D1-B427-C5705A7260C4Q27628727-BB68F4CB-A0CA-43AE-B30E-EDA1505936BCQ28369078-66493EA6-251A-4390-9D11-BB6D5077F21EQ30500267-3A6B271F-D32D-4B6F-B377-2C2A01F62AF0Q33774299-2F900B0E-3B98-432A-8EC7-2C0063062DBEQ33847497-1E229A6B-1B8B-45A1-857C-A85AAB369F89Q34193685-403690B2-3306-49E2-8A61-19A8CAD709C9Q34381818-D5467A0F-AF22-4E73-964C-9255D3ED31BBQ34593085-A3C97A45-4447-4BB4-AE42-11CDC3B4F499Q34683911-B63B084B-8B37-4574-B521-7178F2B1A932Q34789755-ED2BDB8F-82A0-4747-BA25-86C8F1B772BEQ34995850-F82DFDE9-64B6-4484-831B-5513EDB763AFQ35015668-F8CC83DE-6FD2-4394-9DD3-AA1026ECA4C8Q35351996-DACE3313-FB8D-482C-A6A6-06C26F2EC4B6Q35746765-3B8DB419-5D52-4422-9270-8091812D2E19Q35829757-DFA753EC-BF6E-4D6D-95A4-7AD7D1B0731FQ35910393-D2092B1F-0BE7-4D69-B610-5107944C2124Q36301061-E9DEFCA8-BFE4-4AE6-81CF-25D78AE65F8BQ36375147-188BE0C7-3557-406E-957F-E953ADE7CCA1Q37038009-E0D9446B-C22E-4C54-9F00-935975EACC6EQ37694434-4113553A-0C57-46EF-9E1E-3CC2D0FCEF29Q38240110-FDBCF526-8F8D-4469-BB78-337E89428F76Q39511258-1EEE965E-C050-4560-B3B5-9469841E0E8DQ39812178-B2EACE05-6F3C-4961-A77E-ADE31074062FQ40240186-526FFD58-BCB2-49B9-97A1-2761731E9AB2Q40851731-06F831B2-DB4A-4718-A4E2-CCD299DC3F5CQ42004172-C52A5510-7514-4CD8-9772-679E15D8657DQ42148044-72CC090A-5435-47F9-9EAE-C9E63936B60EQ42199873-60791463-7FE5-466C-8D86-E85DED8088A9Q52313647-0AEBC165-C7F3-4345-AE96-C9944A9D9771Q55691049-E8E13E77-AA77-4BE0-B9F9-EB875F9DE12C
P2860
Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II
description
1994 nî lūn-bûn
@nan
1994 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Characterization of a novel tu ...... cyte activating polypeptide II
@ast
Characterization of a novel tu ...... cyte activating polypeptide II
@en
Characterization of a novel tu ...... cyte activating polypeptide II
@nl
type
label
Characterization of a novel tu ...... cyte activating polypeptide II
@ast
Characterization of a novel tu ...... cyte activating polypeptide II
@en
Characterization of a novel tu ...... cyte activating polypeptide II
@nl
prefLabel
Characterization of a novel tu ...... cyte activating polypeptide II
@ast
Characterization of a novel tu ...... cyte activating polypeptide II
@en
Characterization of a novel tu ...... cyte activating polypeptide II
@nl
P2093
P1476
Characterization of a novel tu ...... cyte activating polypeptide II
@en
P2093
Greenberg S
Grikscheit T
Libutti SK
Nowygrod R
P304
25106-25119
P407
P577
1994-10-01T00:00:00Z